Assignee
ANNEXON INC
US13 patents
Top patents by PatentIndex Score
US9708394B2Jul 18, 2017
Anti-complement factor C1q antibodies and uses thereof
ANNEXON INC10 citations92
US10927167B2Feb 23, 2021
Anti-complement factor C1Q antibodies and uses thereof
ANNEXON INC4 citations83
US10590190B2Mar 17, 2020
Anti-complement factor C1q antibodies and uses thereof
ANNEXON INC8 citations83
US10316081B2Jun 11, 2019
Humanized anti-complement factor C1Q antibodies
ANNEXON INC10 citations83
US10227398B2Mar 12, 2019
Anti-complement factor C1q antibodies and uses thereof
ANNEXON INC8 citations83
US10723788B2Jul 28, 2020
Anti-complement factor C1q Fab fragments and uses thereof
ANNEXON INC6 citations81
US11649279B2May 16, 2023
Anti-complement factor C1Q antibodies and uses thereof
ANNEXON INC2 citations72
US11999779B2Jun 4, 2024
Anti-complement factor C1q Fab fragments and uses thereof
ANNEXON INC2 citations70
US11814404B2Nov 14, 2023
Inhibitors of complement factors and uses thereof
ANNEXON INC2 citations65
US12534522B2Jan 27, 2026
Anti-complement factor C1q antibodies and uses thereof
ANNEXON INC0 citations62
US12486322B2Dec 2, 2025
Anti-complement factor C1q antibodies with single binding arms and uses thereof
ANNEXON INC0 citations57
US12509474B2Dec 30, 2025
Inhibitors of complement factors and uses thereof
ANNEXON INC0 citations55
US12522619B2Jan 13, 2026
Inhibitors of complement factors and uses thereof
ANNEXON INC0 citations43